$701 Million is the total value of BERNZOTT CAPITAL ADVISORS's 46 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 14.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SP | Sell | SP Plus | $34,050,000 | +17.9% | 862,030 | -8.8% | 4.86% | +2.1% |
| CTLT | Sell | Catalent | $32,158,000 | +10.1% | 805,565 | -3.2% | 4.59% | -4.6% |
| SNPS | Sell | Synopsys | $29,097,000 | +9.0% | 361,316 | -1.3% | 4.15% | -5.6% |
| ABCO | Sell | Advisory Board | $26,437,000 | -13.5% | 492,990 | -16.9% | 3.77% | -25.1% |
| LDR | Sell | Landauer | $26,362,000 | +12.7% | 391,712 | -12.4% | 3.76% | -2.4% |
| HRC | Sell | Hill-Rom Holdings | $19,076,000 | -12.6% | 257,788 | -6.0% | 2.72% | -24.4% |
| CSCO | Sell | Cisco | $10,806,000 | +5.6% | 321,328 | -1.7% | 1.54% | -8.5% |
| MSFT | Sell | Microsoft | $8,686,000 | -22.7% | 116,610 | -28.5% | 1.24% | -33.1% |
| JNJ | Sell | Johnson & Johnson | $8,090,000 | -4.0% | 62,225 | -2.3% | 1.15% | -16.9% |
| ORCL | Sell | Oracle | $7,072,000 | -7.3% | 146,262 | -3.8% | 1.01% | -19.7% |
| TMO | Sell | Thermo Fisher Scientific | $5,362,000 | +7.4% | 28,338 | -1.0% | 0.76% | -6.9% |
| INTC | Sell | Intel | $5,191,000 | +12.6% | 136,309 | -0.3% | 0.74% | -2.6% |
| VZ | Sell | Verizon | $5,179,000 | +5.6% | 104,646 | -4.7% | 0.74% | -8.5% |
| PG | Sell | Procter & Gamble | $4,934,000 | +3.2% | 54,227 | -1.2% | 0.70% | -10.7% |
| PEP | Sell | Pepsico | $4,305,000 | -4.2% | 38,631 | -0.7% | 0.61% | -17.0% |
| ZBH | Sell | Zimmer Biomet | $3,110,000 | -9.5% | 26,559 | -0.8% | 0.44% | -21.6% |
| VEU | Sell | Vanguard VEUetf | $2,361,000 | -17.6% | 44,796 | -21.8% | 0.34% | -28.6% |
| VOO | Sell | Vanguard VOOetf | $1,450,000 | -11.1% | 6,285 | -14.4% | 0.21% | -23.0% |
| BCOV | Exit | Brightcove | $0 | – | -10,815 | -100.0% | -0.01% | – |
| VTI | Exit | Vanguard VTIetf | $0 | – | -13,620 | -100.0% | -0.28% | – |
| PM | Exit | Philip Morris | $0 | – | -20,930 | -100.0% | -0.40% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-11-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HILLENBRAND INC | 42 | Q3 2023 | 5.3% |
| GENTEX CORP | 42 | Q3 2023 | 4.4% |
| JOHNSON & JOHNSON | 42 | Q3 2023 | 2.3% |
| PEPSICO INC | 42 | Q3 2023 | 1.6% |
| Zimmer Holdings | 42 | Q3 2023 | 1.7% |
| CISCO SYS INC | 41 | Q2 2023 | 2.3% |
| VERIZON COMMUNICATIONS INC | 41 | Q2 2023 | 1.4% |
| SP PLUS CORP | 40 | Q3 2023 | 5.2% |
| COMPASS MINERALS INTL INC | 40 | Q1 2023 | 4.9% |
| INTEL CORP | 37 | Q2 2022 | 1.8% |
View BERNZOTT CAPITAL ADVISORS's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Mistras Group, Inc. | April 30, 2020 | 1,875 | 0.0% |
| Manning & Napier, Inc. | March 16, 2017 | 125,218 | 0.9% |
| QUAKER CHEMICAL CORP | November 14, 2005 | 2,400 | 0.0% |
View BERNZOTT CAPITAL ADVISORS's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-01 |
| 13F-HR | 2024-02-12 |
| 13F-HR | 2023-10-23 |
| 13F-HR | 2023-07-27 |
| 13F-HR | 2023-04-27 |
| 13F-HR | 2023-01-18 |
| 13F-HR/A | 2022-12-22 |
| 13F-HR | 2022-10-18 |
| 13F-HR | 2022-07-25 |
| 13F-HR | 2022-04-20 |
View BERNZOTT CAPITAL ADVISORS's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.